In conversation with Endpoints News Senior Editor, Amber Tong
Join us in conversation with Amber Tong, Senior Editor at Endpoints News for the third instalment of our “meet the journalist” sessions. Amber will join Carolyn Armstrong, Associate Director at AXON Communications to explore topics from best practices for working with media to hot topics and predictions for biopharma and R&D in 2024.
The session will be hosted as a virtual webinar and will include a Q&A session where you’ll have the opportunity to ask Amber your own questions.
The meeting will take place 09:00-10:00am
Session Agenda:
- 9.00am: Welcome
- 9.05am: Interview-style session with Amber Tong, to include:
- Life as a journalist – insights from Amber’s career, key learnings, and topics of personal interest.
- Best practices for working with media and pitching stories
- Predictions of hot topics for biopharma and R&D in 2024
- 9.45am – Q&A
- 10.00am – Meeting close
Biography: Amber Tong
Amber Tong is a senior editor at Endpoints News, a leading source of news and analysis for the thriving biopharmaceutical industry and a member of the Financial Times Group.
In addition to writing on the biggest scientific and business updates of the day, she steers coverage decisions for the newsroom and sets the agenda before the US and Europe are awake. She has a particular focus on oncology, and how technologies developed for cancer are being used in other diseases. Working out of Hong Kong, she has also helped bring attention to the growing role Asia plays on the global biopharma stage.
Amber is a graduate of Rice University, with a degree in anthropology, and has lived in Houston and Sheffield.
Recent articles from Amber:
